Effectiveness Research on Smoking Cessation in Hospitalized Patients Research Coordinating Unit (U01)

The summary for the Effectiveness Research on Smoking Cessation in Hospitalized Patients Research Coordinating Unit (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Effectiveness Research on Smoking Cessation in Hospitalized Patients Research Coordinating Unit (U01): Purpose. The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) solicits four-year cooperative agreement (U01) grant applications from institutions/organizations to serve as the Research Coordinating Unit (RCU) for the grantees of the Effectiveness Research on Smoking Cessation in Hospitalized Patients (see RFA-HL-10-020), referred to as primary research sites (PRSs). The purpose of the PRS FOA (RFA-HL-10-020) is to encourage research to evaluate the translation of efficacious smoking cessation strategies initiated during hospitalization and continued post-discharge into effective programs that can be widely implemented in routine clinical practice, and assess the cost effectiveness of these interventions. NHLBI, NIDA, and NCI expect to award $21.1 million over four years to fund five to six awards under the companion announcement (RFA-HL-10-020) The RCU solicited by this FOA (RFA HL-10-025) will facilitate coordination of research activities of the PRSs awarded under the parallel FOA. The PRSs will be responsible for planning, directing, and executing their own studies and conducting their own data management and statistical analyses. The RCU awardee will be responsible for: (a) planning, arranging, and supporting meetings of the Steering Committee and its subcommittee to facilitate the use of common measures, methods, and data management procedures of the PRSs; (b) supporting and coordinating the semi-annual meetings of the DSMB appointed by NHLBI; and (c) providing the infrastructure for data aggregation and data sharing across PRSs. Mechanism of Support. This FOA will utilize the Cooperative Agreement grant mechanism (U01). A companion FOA (RFA HL-10-020) solicits U01 applications for Primary Research Sites (PRSs) to plan, direct, and execute studies on smoking cessation in hospitalized patients. Funds Available and Anticipated Number of Awards. NHLBI expects to award $600,000 in total costs over four years to fund one Research Coordinating Unit (RCU) through this announcement. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Effectiveness Research on Smoking Cessation in Hospitalized Patients Research Coordinating Unit (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-10-025
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.837
CFDA Descriptions: Heart and Vascular Diseases Research
Current Application Deadline: Jan 19, 2010
Original Application Deadline: Jan 19, 2010
Posted Date: Nov 16, 2009
Creation Date: Nov 16, 2009
Archive Date: Feb 19, 2010
Total Program Funding: $600,000
Maximum Federal Grant Award: $400,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not All...
Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)
Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowe...
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50)
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and...
The Relationship Between Hypertension and Inflammation
Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 ...
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Scree...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com